Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effects of Jianpi Lushi Jiedu Formula on postoperative recurrence of colorectal adenoma with spleen deficiency and dampness syndrome and its mechanism based on IL-6/JAK/STAT3 signaling pathway

ABSTRACT: Interventions: test group:Oral Chinese medicine;control group:Not taking medicine Primary outcome(s): Recurrence rate of colorectal adenoma Study Design: Case-Control study

DISEASE(S): Colorectal Adenoma

PROVIDER: 80024 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Clinical effect of Jianpi Lishi Jiedu Decoction on postoperative patients with spleen deficiency and dampness toxin type colorectal adenoma

Project description:Interventions: The experimental group:Chinese medicine Jianpi Lishi Jiedu recipe, twice a day, 25ml each time, 1 hour after breakfast and dinner, course of 3 months;The control group:Follow up and observation Primary outcome(s): Main symptoms of Patiens;Curative effect of TCM Syndrome;Recurrence rate of colorectal adenoma;Safety indicators (such as routine hematuria feces, liver and kidney function, ECG);Beta-catenin Study Design: Parallel

| 2704459 | ecrin-mdr-crc

Therapeutic Effect and Mechanism of Bushen-Jianpi-Jiedu Decoction Combined with Chemotherapeutic Drugs on Postoperative Colorectal Cancer.

Project description: Not available

| S-EPMC8020259 | biostudies-literature

Clinical study on the treatment of stage III - IV colorectal cancer of spleen deficiency and essence deficiency type with anticancer essence formula

Project description:Interventions: blank control group:Blank intervention;Chinese medicine experimental group:Oral administration of Kangai Jingfang Primary outcome(s): quality of life Study Design: Parallel

| 2698077 | ecrin-mdr-crc

Potential Mechanism of Chinese herbal formula Sijunzi Decoction in Treating Gastric Cancer

Project description:Establishment 615 mouse subcutaneous tumor model using mouse derived gastric cancer cell lines (MFC)，and intervention with traditional Chinese medicine（Sijunzi Decoction）. The mice model were indived into Model group(model), early Sijunzi Decoction (E-SJZD), synchronization Sijunzi Decoction (S-SJZD).The size of GC tumor changes and body weight in these groups of 615 mice were observed. The mRNA-seq analysis of mouse models and the network pharmacology technology based on TCM Systems Pharmacology database and Swiss target prediction were used to predict corresponding potential target genes of SJZD.

2025-10-31 | E-MTAB-15788 | biostudies-arrayexpress

Multi-omics analysis reveals Jianpi formula-derived bioactive peptide-YG-22 potentially inhibited colorectal cancer via regulating epigenetic reprogram and signal pathway regulation [ChIP-Seq]

Project description:Colorectal cancer (CRC) is a prevalent malignancy worldwide, often treated with chemotherapy despite its limitations, including adverse effects and resistance. Chemotherapy combined with the traditional Chinese medicine (TCM) Jianpi formula has been demonstrated to improve efficacy. In this study, we aim to screen bioactive peptides derived from the blood of CRC patients through peptidomics and explore the molecular mechanisms of the candidate peptides in HCT116 cells using multi-omics analysis. Differential peptides were identified in plasma samples from patients treated with chemotherapy alone and those receiving the combined therapy. Among these, YG-22 exhibited the strongest cytotoxic effect on HCT116 cells, reducing viability in a dose- and time-dependent manner. Transcriptome analysis highlighted the modulation of key pathways involved in lysosome-mediated degradation and apoptosis, while metabolomic profiling indicated disruptions in tumor-supportive metabolic pathways. Additionally, chromatin accessibility and histone modifications suggested epigenetic reprogramming induced by YG-22. These findings demonstrate that combining chemotherapy with TCM enriches the molecular landscape and generates bioactive peptides with strong antitumor activity. Furthermore, this study also lays the foundation for further development of peptide-based therapies and highlights the value of combining traditional and modern therapeutic strategies for CRC management.

2025-03-26 | GSE289007 | GEO

Multi-omics analysis reveals Jianpi formula-derived bioactive peptide-YG-22 potentially inhibited colorectal cancer via regulating epigenetic reprogram and signal pathway regulation [ATAC-seq]

2025-03-26 | GSE289006 | GEO

Multi-omics analysis reveals Jianpi formula-derived bioactive peptide-YG-22 potentially inhibited colorectal cancer via regulating epigenetic reprogram and signal pathway regulation [RNA-Seq]

2025-03-26 | GSE289008 | GEO

Spleen-Kidney Supplementing Formula Alleviates Renal Fibrosis in Diabetic Rats via TGF-<i>β</i>1-miR-21-PTEN Signaling Pathway.

Project description: Not available

| S-EPMC6304600 | biostudies-literature

Effects of Jianpi Huayu Decoction on Th1/Th2 Immune Balance in Mice With Liver Cancer-Related Fatigue via the IL- 27/STAT1 Signaling Pathway.

Project description: Not available

| S-EPMC11289807 | biostudies-literature

Jianpi Yangxue Qufeng compound alleviates atopic dermatitis via TLR4/MyD88/NF-κB signaling pathway.